FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for ... - The Globe and Mail

Retrieved on: 2024-02-16 17:03:18

Tags for this article:

COVID-19 drug development

Nitriles

Antiviral drugs

Remdesivir

Cycloserine/lurasidone

Emergency use authorization

Aviptadil

Food and Drug Administration

EUA

Relief Therapeutics

NRx Pharmaceuticals Inc.

Click the tags to see associated articles and topics

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for ... - The Globe and Mail. View article details on hiswai:

Excerpt

... remdesivir. PR Newswire - Fri Jul 1, 2022. Focus is now on NRX-101 for Bipolar Depression with Suicidality. RADNOR, Pa., July 1, 2022 /PRNewswire ...

Article found on: www.theglobeandmail.com

View Original Article